by roseandgold | Apr 6, 2024 | Eco-Friendly Pharmacy Services, Mylyfe, Mylyfe Specialty Pharmacy, Specialty Pharmacy, Sustainable Medication Packaging
As Earth Month approaches, the global community gears up to celebrate environmental consciousness and take actionable steps toward sustainability, and we are proud to be a part of this movement. At Mylyfe Specialty Pharmacy, we recognize the importance of reducing...
by roseandgold | Mar 25, 2024 | Advocacy, Bleeding Disorders, Chronic Conditions, Community, Encouragement, Hemophilia, Hemophilia Awareness, Hemophilia Caregivers, Mylyfe, Support
Living with a genetic bleeding disorder has many challenges, not just for the individuals diagnosed with the condition but also for their caregivers. Hemophilia caregivers are vital in managing the daily needs, emotional support, and medical care of those living with...
by roseandgold | Mar 14, 2024 | Bleeding Disorders, Chronic Conditions, Genetic Bleeding Disorder, Hemophilia, Hemophilia Awareness, Hemophilia Treatment, Mylyfe
March is more than just a month—it’s a time to stand up for those living with hemophilia and all bleeding disorders. Hemophilia Advocacy Month shines a spotlight on the challenges faced by individuals and families who live with a genetic bleeding disorder. As we...
by roseandgold | Feb 22, 2024 | Bleeding Disorders, Chronic Conditions, Hemophilia, Mylyfe, Specialty Pharmacy
Living with hemophilia isn’t just about managing a medical condition; it’s about navigating a unique journey that requires support, understanding, and personalized care. In this blog, we’ll explore how specialty pharmacies are making a real...
by roseandgold | Feb 14, 2024 | Bleeding Disorders, Chronic Conditions, Hemophilia, Mylyfe, Patient Education, Specialty Pharmacy
Hemophilia is a rare genetic disorder characterized by a deficiency in clotting factors, which leads to prolonged bleeding episodes and impaired blood clotting. Individuals with hemophilia face unique challenges in managing their condition, requiring specialized care...
